MAPT and Alzheimer disease: The rationale behind selecting [11C]PiB and [18F]THK-5317 as radiotracers to characterize our APP/Tau rat model was that both radiotracers have been employed before in rat models of AD and have provided an increase in signal with age [27, 28].